Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

S. Stensen, L. S. Gasbjerg, M. M. Rosenkilde, B. Hartmann, T. Vilsboll, J. J. Holst, M. B. Christensen, F. K. Knop

Original languageEnglish
Publication dateSep 2021
Publication statusPublished - Sep 2021

Cite this